Skip to content

GORE-TEX Stretch Vascular Graft S46045Recalls & reported problems

W. L. Gore & Associates, Inc. · STRETCH VASCULAR GRAFT SW 4-6mmX45cm Tapered · Class 2 · Implant

All models of GORE-TEX Stretch Vascular Graft (10)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00733132611492), received between Aug 30, 2023 and Sep 4, 2023 — classified as 2 injuries.

The most frequently reported specific device problem is “Complete Blockage” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Complete Blockage1
  • Partial Blockage1
  • Patient-Device Incompatibility1

Patient problems

  • Obstruction/Occlusion1
  • Reduced Blood Flow1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjurySep 4, 2023Patient-Device Incompatibility; Patient-Device Incompatibility

    GORE RECEIVED AN ADVERSE EVENT ALERT FROM A RETROSPECTIVE VASCULAR GRAFT STUDY. ON (B)(6) 2016, THE PATIENT UNDERWENT SURGICAL TREATMENT FOR A HUMERO AXILLARY DIALYSIS ACCESS WITH A GORE-TEX® STRETCH VASCULAR GRAFT. THE DEVICE WAS IMPLANTED AND RETAINED AND THERE WERE NO ADVERSE EVENTS DURING THE PROCEDURE. THE PATIENT WAS DISCHARGED HOME 1 WEEK LATER. THE FIRST ORDER TO DIALYZE THROUGH THE GRAFT WAS ON (B)(6) 2016 AND WAS SUCCESSFUL. ON (B)(6) 2016, THE PATIENT PRESENTED WITH A VASCULAR STEAL SYNDROME ON THE HUMERO-AXILLARY PROSTHETIC LINE. PROFESSOR RINCKENBACH STATED THAT THERE IS NO ALLEGATION AGAINST THE GORE-TEX STRETCH VASCULAR GRAFT AND THAT THE GRAFT DID NOT CONTRIBUTE TO THE STEAL SYNDROME. THERE WAS A REINTERVENTION ON (B)(6) 2016, NAMELY BANDING OF THE ARTERIO-VENOUS ANASTOMOSIS. THE PATIENT WAS DISCHARGED HOME ON (B)(6) 2016 AND AN ULTRASOUND PERFORMED ON (B)(6) 2016 SHOWED THAT EVERYTHING WAS OK.

    Patient problems: Reduced Blood Flow

    MAUDE report 17675909 ↗
  • InjuryAug 30, 2023Partial Blockage; Complete Blockage; Partial Blockage; Complete Blockage

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2016, THE PATIENT UNDERWENT SURGICAL TREATMENT FOR THE CREATION OF A VASCULAR ACCESS GRAFT FOR HEMODIALYSIS WITH A GORE-TEX® VASCULAR GRAFT, THE ACCESS CONFIGURATION WAS RECORDED AS HUMERO-AXILLARY CONFIGURATION. DURING THE PROCEDURE ANTICOAGULANT / ANTIPLATELET WAS USED AND THE DEVICE WAS IMPLANTED; RETAINED SUCCESSFULLY AND NO ADVERSE EVENT WAS REPORTED DURING THE PROCEDURE. ON (B)(6) 2016, AN ADVERSE EVENT TERMED "THROMBOSIS OF THE LEFT HUMERO-AXILLARY PROSTHETIC LINE (GORE GRAFT THROMBOSED))" WAS DISCOVERED AND THE PRIMARY RELATIONSHIP WAS RECORDED AS DISEASE RELATED. NO REINTERVENTION WAS PERFORMED AND THE PATIENT RECOVERED WITHOUT A SEQUELEA.

    Patient problems: Obstruction/Occlusion; Thrombosis/Thrombus

    MAUDE report 17649140 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page